Episode

Colorectal Cancer: The Hidden Drivers

Podcast
DoctoRx Unscripted
Published
Oct 16, 2025
Duration seconds
3467
Processing state
not_requested
Canonical source
https://doctorx-unscripted.podbean.com/e/colorectal-cancer-the-hidden-drivers/
Audio
https://mcdn.podbean.com/mf/web/doefmi2bt9wiyw3a/72f53d09-e95b-4752-996f-27bd66441a21_episodes_ff25884b-3575-4a31-aedb-cc48481c1a12_audio_128_default.mp3
JSON
/v1/public/podcasts/doctorx-unscripted-7398035/episodes/colorectal-cancer-the-hidden-drivers
Markdown
/podcast/doctorx-unscripted-7398035/colorectal-cancer-the-hidden-drivers.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/doctorx-unscripted-7398035/episodes/colorectal-cancer-the-hidden-drivers/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/doctorx-unscripted-7398035/colorectal-cancer-the-hidden-drivers.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr. Tania Small sits down with Dr. Heinz-Josef Lenz, one of the world’s greatest minds in gastrointestinal medical research, for a thought-provoking conversation on the future of colorectal cancer (CRC) care. Together, they unpack the rising incidence of early-onset CRC and the factors driving the surge of new cases in younger patients. This conversation dives into cutting-edge innovations that are reshaping detection and treatment: • ctDNA liquid biopsies and minimal residual disease testing - revolutionizing how relapse is detected. • Next-generation diagnostics and precision screening, including AI-assisted colonoscopies - enabling earlier, more accurate identification. • Methylation profiling, tumor microenvironment and epigenetic therapies - advancing personalized therapy and novel treatments. • Immunotherapies and targeted agents - moving to the “front line” with the potential to transform treatment approaches into organ-preserving strategies. But the conversation doesn’t stop at science. Together, they examine the influence of lifestyle, disparities in access, and patient-driven data on survival. If you’re driving change in oncology, this episode offers practical insights on integrating molecular testing, rethinking prevention, and preparing for the innovations ahead.